Related Experiment Video

Updated: Jul 12, 2026

Mouse Round Spermatid Injection
08:41

Mouse Round Spermatid Injection

Published on: January 26, 2024

New insights and unresolved issues regarding insertional mutagenesis in X-linked SCID gene therapy

Karin Pike-Overzet1, Mirjam van der Burg, Gerard Wagemaker

  • 1Department of Immunology, Erasmus MC, Erasmus University Medical Center, Rotterdam, The Netherlands.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|August 30, 2007
PubMed

Insights

Retrovirus gene therapy for X-linked severe combined immunodeficiency (X-linked SCID) risks T-cell acute lymphoblastic leukemia (T-ALL). Researchers explore oncogene roles and viral contributions to T-ALL development in SCID patients.

Area of Science:

  • Immunology
  • Oncology
  • Gene Therapy

Background:

  • Severe combined immunodeficiency (SCID) encompasses disorders lacking T cells, B cells, and/or NK cells.
  • X-linked SCID results from inactivating mutations in the IL2Rgamma gene.
  • Retrovirus gene therapy offers potential treatments for SCID but carries oncogenic risks.

Purpose of the Study:

  • To review SCID forms and normal T-cell development.
  • To investigate the role of LMO2 and other T-ALL oncogenes in adverse events following X-linked SCID gene therapy.
  • To analyze the contribution of retroviral integration and IL2RG gene expression to leukemogenesis.

Main Methods:

  • Literature review of SCID, T-cell development, and gene therapy trials.
  • Analysis of T-cell acute lymphoblastic leukemia (T-ALL) oncogenes, including LMO2.
  • Examination of retroviral integration patterns and gene expression in SCID patients.

Main Results:

  • Gene therapy for X-linked SCID led to T-ALL-like disease in four patients.
  • Integration near the LMO2 locus and/or gamma-retroviral expression of IL2RG may contribute to T-ALL development.
  • Newly developed murine models are being assessed for gene therapy safety studies.

Conclusions:

  • Retrovirus-mediated gene therapy for X-linked SCID requires careful safety evaluation due to T-ALL risks.
  • Understanding oncogene involvement and viral mechanisms is crucial for safer gene therapy strategies.
  • Further research using preclinical models is essential to mitigate adverse effects in SCID gene therapy.

More Related Videos

Assessing Somatic Hypermutation in Ramos B Cells after Overexpression or Knockdown of Specific Genes08:12

Assessing Somatic Hypermutation in Ramos B Cells after Overexpression or Knockdown of Specific Genes

Published on: November 1, 2011

A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome08:27

A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome

Published on: May 22, 2019

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
In vitro Mutagenesis01:16

In vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.